Total Brain Licenses iSPOT-D for Depression Research to Alto Neuroscience

SAN FRANCISCO: SAN FRANCISCO, Jan. 5, 2022 /PRNewswire/ -- Total Brain, a mental health monitoring and support platform, today announced that the company will license its International Study to Predict Optimized Treatment for Depression (iSPOT-D) research data to Alto Neuroscience, a pioneer in precision psychiatric medicine. Alto Neuroscience will analyze...

Click to view original post